Hualan Biological Engineering Inc
Company Profile
Business description
Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, recombinant proteins, and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin, and others. The vaccine products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine, and others. It also offers gene products such as Monoclonal Antibodies for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.
Contact
No. 1, Hualan Avenue
Henan Province
Xinxiang453003
CHNT: +86 3733559989
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
4,012
Stocks News & Analysis
stocks
Our three most overvalued ASX shares
stocks
What does big US court decision mean for Google’s parent company Alphabet?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,126.90 | 2.50 | -0.03% |
CAC 40 | 7,742.73 | 43.81 | 0.57% |
DAX 40 | 23,824.10 | 227.12 | 0.96% |
Dow JONES (US) | 45,473.77 | 147.52 | -0.32% |
FTSE 100 | 9,232.92 | 24.71 | 0.27% |
HKSE | 25,633.91 | 215.93 | 0.85% |
NASDAQ | 21,870.43 | 162.73 | 0.75% |
Nikkei 225 | 43,643.81 | 625.06 | 1.45% |
NZX 50 Index | 13,281.14 | 57.61 | 0.44% |
S&P 500 | 6,505.20 | 23.70 | 0.37% |
S&P/ASX 200 | 8,849.60 | 5.60 | -0.06% |
SSE Composite Index | 3,826.84 | 14.33 | 0.38% |